Form 4 for LXEO Lexeo Therapeutics, Inc.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0000950170-24-003464 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-01-09 | 2024-01-05 | LXEO | Robertson Jenny | Chief Legal, Admin Off | A - Grant | $0.00 | +23.8K | 23.8K | New | $0 |
| DT | 2024-01-09 | 2024-01-05 | LXEO | Robertson Jenny | Chief Legal, Admin Off | A - Grant | $0.00 | +142.5K | 142.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-05 | A | A | 23,750 | $0.00 | 23,750 | D | — | — | (F1) The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-05 | A | A | 142,500 | $0.00 | 142,500 | D | $14.48 · — to 2034-01-04 | 142,500 Common Stock | (F2) 25% of the shares underlying the option shall vest on January 5, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |